Direct to consumer pharmacy and formation as pharmacy benefit manager further mission to drastically expand access to affordable pharmaceuticals
Acute therapies continue to report strong growth compared to chronic ones.
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
The drug is also intended for the treatment of glioblastoma multiforme
Subscribe To Our Newsletter & Stay Updated
